Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000646840 | SCV000768625 | likely benign | Rhabdoid tumor predisposition syndrome 2 | 2024-07-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002483866 | SCV002787266 | uncertain significance | Rhabdoid tumor predisposition syndrome 2; Intellectual disability, autosomal dominant 16 | 2021-07-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003392489 | SCV004120803 | uncertain significance | SMARCA4-related disorder | 2023-08-18 | criteria provided, single submitter | clinical testing | The SMARCA4 c.4732-10C>A variant is predicted to interfere with splicing. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. It is interpreted as uncertain significance in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/537794/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Baylor Genetics | RCV000646840 | SCV004204954 | uncertain significance | Rhabdoid tumor predisposition syndrome 2 | 2023-07-25 | criteria provided, single submitter | clinical testing |